(EIGR) Eiger Biopharmaceuticals Weekly charts technical analysis
(EIGR) Eiger Biopharmaceuticals Weekly charts technical analysis Weekly analysis of Eiger Biopharmaceuticals | Buy/Sell Eiger Biopharmaceuticals
Eiger Biopharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Eiger Biopharmaceuticals is 637050
Date | Closing Price | Open | High | Low | Volume |
10 Wed Apr 2024 | 1.73 | 2.21 | 2.24 | 1.66 | 0.386 Mn |
05 Fri Apr 2024 | 2.30 | 5.20 | 5.24 | 1.10 | 6.094 Mn |
28 Thu Mar 2024 | 5.01 | 5.82 | 6.15 | 4.79 | 0.036 Mn |
22 Fri Mar 2024 | 5.76 | 5.16 | 7.20 | 4.81 | 0.219 Mn |
15 Fri Mar 2024 | 5.14 | 6.78 | 7.26 | 5.14 | 0.056 Mn |
08 Fri Mar 2024 | 6.91 | 7.10 | 8.27 | 6.12 | 0.053 Mn |
01 Fri Mar 2024 | 7.00 | 5.70 | 8.01 | 5.53 | 0.055 Mn |
23 Fri Feb 2024 | 5.41 | 5.73 | 5.98 | 5.12 | 0.02 Mn |
16 Fri Feb 2024 | 5.73 | 5.85 | 6.23 | 5.68 | 0.032 Mn |
09 Fri Feb 2024 | 5.76 | 6.71 | 6.77 | 5.76 | 0.026 Mn |
Indicators analysis of Eiger Biopharmaceuticals (EIGR)
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eiger Biopharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Eiger Biopharmaceuticals in short term but the sell signal is initial and weak.
Eiger Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Eiger Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eiger Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.52 and Eiger Biopharmaceuticals (EIGR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eiger Biopharmaceuticals (EIGR) stock. Volume based technical analysis of Eiger Biopharmaceuticals (EIGR) stock is negative.
Eiger Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eiger Biopharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Eiger Biopharmaceuticals in short term but the sell signal is initial and weak.
Eiger Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Eiger Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eiger Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.52 and Eiger Biopharmaceuticals (EIGR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eiger Biopharmaceuticals (EIGR) stock. Volume based technical analysis of Eiger Biopharmaceuticals (EIGR) stock is negative.
Eiger Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.